July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug ...
The Sunday Guardian Live on MSN
Central government's CDSCO grants approval to Novo Nordisk's Wegovy drug for treatment of liver diseases in India - check price, side effects & more
India, July 17 -- Did you know that nearly 4 in 10 Indian adults suffer from fatty liver disease? Now the Central Drugs ...
Transjugular intrahepatic portosystemic shunt insertion is associated with a lower risk for short-term mortality in patients ...
Silent liver disease: There is a type of liver disease which is seen in young adults more often these days. Learn why it is ...
Silent liver disease may affect 1 in 60 adults over 40, and researchers say early screening could catch damage before ...
An experimental drug called DT-109 reversed severe fatty liver disease in animal studies by repairing the gut and preventing harmful toxins from damaging the liver. The discovery could open the door ...
A study led by researchers at Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), the University of Cambridge ...
Novo Nordisk's Wegovy receives CDSCO approval as India's first GLP-1 treatment for fatty liver disease, addressing rising ...
Acute liver failure is a medical emergency that can cause life threatening complications. It’s most commonly caused by drug overdose in the United States, with acetaminophen being the most common ...
A recent study is raising new questions about whether cannabis-derived compounds could one day play a role in liver care.
Everyday Health on MSN
Coffee May Lower the Risk of Serious Liver Disease
A new study of more than 350,000 people suggests coffee, regular and decaf, may protect against serious liver ailments. Learn ...
Delhi doctors successfully performed rare twin liver transplants on Filipino toddlers. The mother and maternal uncle served ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results